SEC 13F Intelligence

Nvp Associates, LLC / ZBIO

Nvp Associates, LLC’s Zenas Biopharma Inc Position

Does Nvp Associates, LLC own Zenas Biopharma Inc (ZBIO)? Yes1.84M shares worth $36M (+20.40% of its 13F portfolio) as of Q1 2026.

Position Value
$36M
Q1 2026
Shares
1.84M
% of Portfolio
+20.40%
Quarters Held
7
currently held

Position History ZBIO

Reported value by quarter
Q3 ’24: $31MQ3 ’24Q4 ’24: $15MQ4 ’24Q1 ’25: $15MQ1 ’25Q2 ’25: $18MQ2 ’25Q3 ’25: $41MQ3 ’25Q4 ’25: $67MQ4 ’25Q1 ’26: $36MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.84M$36M+20.40%
Q4 20251.84M$67M+26.16%
Q3 20251.84M$41M+24.58%
Q2 20251.84M$18M+9.67%
Q1 20251.84M$15M+12.95%
Q4 20241.84M$15M+8.05%
Q3 20241.84M$31M+17.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nvp Associates, LLC’s full portfolio or all institutional holders of ZBIO.